Company Filing History:
1 out of 3,107 
1 out of 15 Years Active: 2013
Title: The Innovations of Yanjun Pan: A Pioneer in Tetrahydroprotoberberine Compounds
Introduction: Yanjun Pan is a distinguished inventor based in Shanghai, China, known for his significant contribution to the field of pharmacology through his innovation in tetrahydroprotoberberine compounds. With one patent to his name, Pan focuses on developing compounds that have potential therapeutic applications, particularly for disorders such as schizophrenia.
Latest Patents: Yanjun Pan holds a patent titled "Tetrahydroprotoberberine compounds, the synthetic method and the use thereof." This invention encompasses tetrahydroprotoberberines of a specific chemical formula and their physiologically acceptable salts. The patent outlines the use of these compounds in preparing pharmaceutical compositions aimed at treating various medical disorders that are responsive to dopamine receptor ligands.
Career Highlights: Throughout his career, Yanjun Pan has contributed to significant advancements in medicinal chemistry while working with reputable organizations. He has been associated with the Shanghai Institute of Materia Medica, part of the Chinese Academy of Sciences, and has also worked at Topharman Shanghai Co., Ltd. His commitment to innovation has positioned him as a key figure in research and development within the pharmaceutical industry.
Collaborations: Yanjun Pan has collaborated with notable coworkers including Jianfeng Li and Aixiang Liu. These partnerships have further enhanced the scope and impact of his work, facilitating the exploration of innovative solutions in drug development.
Conclusion: Yanjun Pan exemplifies the spirit of innovation through his dedicated research in tetrahydroprotoberberine compounds. His contributions reflect a significant stride toward improved medical treatments, showcasing the vital role of inventors in advancing healthcare solutions.